![dual gip/glp-1 receptor agonist The Sustained Effects of a Agonist, NNC0090-2746, in Patients with Type 2 Diabetes PDF] Novel dual GLP-1/GIP receptor](https://ars.els-cdn.com/content/image/1-s2.0-S1550413117304321-fx1.jpg)
dual gip/glp-1 receptor agonist The Sustained Effects of a Agonist, NNC0090-2746, in Patients with Type 2 Diabetes PDF] Novel dual GLP-1/GIP receptor
Description
It attained FDA approval in 2016 for the management of T2D
![dual gip/glp-1 receptor agonist The Sustained Effects of a Agonist, NNC0090-2746, in Patients with Type 2 Diabetes PDF] Novel dual GLP-1/GIP receptor](https://figures.semanticscholar.org/d83a64f6b7193358c31030487761fc19c80dd33c/3-Figure1-1.png)
Poston L, Caleyachetty R, Cnattingius S, Corvaln C, Uauy R, Herring S, Gillman MW
![dual gip/glp-1 receptor agonist The Sustained Effects of a Agonist, NNC0090-2746, in Patients with Type 2 Diabetes PDF] Novel dual GLP-1/GIP receptor](https://media.licdn.com/dms/image/sync/v2/D5627AQGLiSaKKicJbg/articleshare-shrink_800/articleshare-shrink_800/0/1713742404023?e=2147483647&v=beta&t=4fv3OJHJmPeKOuQIl1zGCTWCWgMwcIRPnXmiac2xbBA)
In an animal study, using a mouse model with different age groups, non-alcoholic steatohepatitis (NASH) was induced, revealing age-dependent effects on cardiac function
![dual gip/glp-1 receptor agonist The Sustained Effects of a Agonist, NNC0090-2746, in Patients with Type 2 Diabetes PDF] Novel dual GLP-1/GIP receptor](https://i.ytimg.com/vi/9M9PQQXqdF8/maxresdefault.jpg)
Structure Therapeutics announces positive results from phase 1b clinical study of oral GLP-1 receptor agonist GSBR-1290 and provides program update(2023)
![dual gip/glp-1 receptor agonist The Sustained Effects of a Agonist, NNC0090-2746, in Patients with Type 2 Diabetes PDF] Novel dual GLP-1/GIP receptor](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb47/8994606/995135ed21d3/DMSO-15-1023-g0002.jpg)
